Clinical Trial Update: NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study completion of NASOBOL in hypogonadal men, assessing safety and pharmacodynamic testosterone-like effects relative to testosterone levels in health…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• NASOBOL

Snippet

Sponsor: Acerus Pharmaceuticals Corporation | Conditions: Hypogonadism | Phase 1 | Status: COMPLETED